当前位置: 首页 > 详情页

PD-1/PD-L1 Interaction Maintains Allogeneic Immune Tolerance Induced by Administration of Ultraviolet B-Irradiated Immature Dendritic Cells

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China [2]Department of Chemotherapy,Weihai Municipal Hospital,Weihai 264200, China [3]Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA
出处:
ISSN:

摘要:
Our previous study demonstrated that transfusion of ultraviolet B-irradiated immature dendritic cells (UVB-iDCs) induced alloantigen-specific tolerance between two different strains of mice. Programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) have been suggested to play an important role in maintaining immune tolerance. In the present study, we seek to address whether PD-1/PD-L1 plays a role in the maintenance of UVB-iDC-induced tolerance. We first observe that the UVB-iDC-induced alloantigen-specific tolerance can be maintained for over 6 weeks. Supporting this, at 6 weeks after tolerance induction completion, alloantigen-specific tolerance is still able to be transferred to syngeneic naive mice through adoptive transfer of CD4+ T cells. Furthermore, skin transplantation study shows that the survival of allogeneic grafts is prolonged in those tolerant recipients. Further studies show that PD-1/PD-L1 interaction is essential for maintaining the induced tolerance as blockade of PD-1/PD-L1 by anti-PD-L1 antibodies largely breaks the tolerance at both cellular and humoral immunological levels. Importantly, we show that PD1/PD-L1 interaction in tolerant mice is also essential for controlling alloantigen-responding T cells, which have never experienced alloantigens. The above findings suggest that PD-1/PD-L1 plays a crucial role in maintaining immune tolerance induced by UVB-iDCs, as well as in actively controlling effector T cells specific to alloantigens.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 3 区 医学
小类 | 3 区 免疫学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 免疫学
JCR分区:
出版当年[2014]版:
Q4 IMMUNOLOGY
最新[2023]版:
Q2 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China [2]Department of Chemotherapy,Weihai Municipal Hospital,Weihai 264200, China
通讯作者:
通讯机构: [1]Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China [3]Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院